SCIENTURE HOLDINGS, INC. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
SCIENTURE HOLDINGS, INC. (SCNX) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of $68.09 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-06-30 was -$209.16K, a 182.30% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2024-03-31 was $277.25K, a 39.56% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2024 was $68.09K.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2023 was -$3.34M.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2022 was -$1.51M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month as first filed | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 6 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 6 month as first filed | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month as first filed | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | -$209.16K derived: sum of 3 quarters · filed 2026-03-30 | $68.09K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$209.16K derived: sum of 2 quarters · filed 2025-11-12 | $68.09K 10-Q · filed 2025-11-12 | -$3.73M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$209.16K 10-Q · filed 2025-08-12 | $68.09K 10-Q · filed 2025-08-12 | $68.09K 10-Q · filed 2024-08-09 | -$3.73M derived: sum of 3 quarters · filed 2025-08-12 | -$3.96M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $277.25K 10-Q · filed 2025-05-12 | $280.75K 10-Q · filed 2024-06-26 | -$3.52M derived: sum of 2 quarters · filed 2025-05-12 | -$3.75M derived: sum of 3 quarters · filed 2025-05-12 | -$3.49M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$4.03M derived: sum of 2 quarters · filed 2025-03-26 | -$3.77M derived: sum of 3 quarters · filed 2025-03-26 | -$3.34M 10-K · filed 2025-03-26 | -$470.56K 10-K · filed 2024-04-22 | |||
| 2023-09-30 | -$227.20K 10-Q · filed 2024-11-06 | -$143.73K 10-Q · filed 2024-01-16 | $26.95K derived: sum of 2 quarters · filed 2024-11-06 | $460.94K 10-Q · filed 2024-11-06 | -$561.01K 10-Q · filed 2024-01-16 | -$397.69K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $254.16K 10-Q · filed 2024-08-09 | $688.14K 10-Q · filed 2024-08-09 | -$170.49K derived: sum of 3 quarters · filed 2024-08-09 | -$360.66K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $458.68K 10-Q · filed 2024-06-26 | -$424.65K derived: sum of 2 quarters · filed 2024-06-26 | -$614.81K derived: sum of 3 quarters · filed 2024-06-26 | |||||
| 2022-12-31 | -$883.33K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | -$1.07M derived: sum of 2 quarters · filed 2024-04-22 | -$1.51M 10-K · filed 2024-04-22 | |||||
| 2022-09-30 | -$190.17K 10-Q · filed 2024-01-16 | -$625.00K 10-Q · filed 2024-01-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |